Clinical trial Recruiting at 1 site Interventional Ages 3 Months to 14

Using inhaled ICG to improve lung surgery in children

Official title: Application of Atomized Inhalation ICG in Thoracoscopic Surgery for Pulmonary Sequestration in Children: a Multicentre Prospective Study

Run by Tongji Hospital · NCT06302985 · Data updated 2026-11-12

This study is testing if inhaling a special dye before lung surgery can help doctors see better and improve outcomes for children with lung problems.

Quick facts

Study typeInterventional
Ages3 Months to 14 Years
SexAll
Enrollment50 (estimated)
SponsorTongji Hospital
Academic / other
Locations1 site (Wuhan, Hubei)
StatusRecruiting
StartedMarch 1, 2024
Main results expectedDecember 31, 2050
Study endsDecember 31, 2050
Registry record updatedOctober 16, 2024
Trial IDNCT06302985 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children diagnosed with congenital lung malformations through CT or MRI scans.

Probably not a fit

Patients under 3 months or over 14 years of age, or those with life-threatening diseases or severe pulmonary infections, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the safety and effectiveness of using aerosolized indocyanine green (ICG) solution before surgery to enhance the accuracy of thoracoscopic resection of congenital lung malformations in children. Patients will inhale the ICG solution 30 minutes prior to surgery, allowing for better visualization of lung lesions during the procedure. The study includes preoperative evaluations and utilizes fluorescence imaging during surgery to differentiate between healthy and affected lung tissue. The goal is to improve surgical outcomes for children with specific lung conditions.

Why it matters

Potential benefit: If successful, this approach could lead to more precise surgical interventions and improved recovery for children with congenital lung malformations.

How similar studies have gone: While the use of ICG in surgical settings has shown promise, this specific application for congenital lung malformations is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* children with congenital lung malformations diagnosed by CT or MRI scan

Exclusion Criteria:

* 1\. ages \<3 months and \>14 years 2. complicated other life-threatening disease; 3. complicated severely pulmonary infection

Where it's running

  • Tongji Hospital
    Wuhan, Hubei, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.